"MHRA approves AstraZeneca’s Trixeo Aerosphere inhaler for COPD" was originally created and published by Pharmaceutical ...

AstraZeneca has announced positive high-level results from its Phase III KALOS and LOGOS trials, showing significant promise ...

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.